Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global venous stents market was valued at USD 1.19 Billion in 2025. It is expected to grow at a CAGR of 8.45% during the forecast period of 2026-2035 and attain a market value of USD 2.68 Billion by 2035. The market growth is driven by the increasing prevalence of chronic venous diseases. Patents are focused on advanced technologies such as iliac vein stent technology and wallstent technology.
Due to decreased mobility and increased rates of comorbidities like obesity and cardiovascular disorders, the elderly population is more vulnerable to venous diseases. This demographic trend is boosting the demand for venous stents as a successful treatment option for enhancing blood circulation.
Improvements in venous stent design, such as increased durability, flexibility, and biocompatibility, have improved patient outcomes and procedural success rates. These developments in technology have expanded the use of venous stents in clinical practice and boosted physician confidence, also impacting the patent landscape significantly.
Venous stents have become more popular as a less invasive substitute for conventional surgical techniques as minimally invasive treatments for venous diseases have shorter recovery times, fewer complications, and lower healthcare costs, patients and healthcare providers are increasingly choosing them.
The Global Venous Stents Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for venous stents include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with venous stents. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within venous stent technologies.

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for venous stents technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with Venous Stents.
A comprehensive summary of several patent applications which were filed across different jurisdictions for venous stents and their relative value are covered. The analysis will cover the capital in terms of innovation and innovation type.
Detailed analysis of the granted patents across different jurisdictions for venous stents and their relative value in the IP are covered in the final report.
Venous stents are tiny, expandable mesh tubes that are inserted into veins to open constricted or obstructed veins and restore normal blood flow. They are frequently used to treat ailments like chronic venous insufficiency (CVI) and deep vein thrombosis (DVT). Venous stents increase blood flow, reduce pain and swelling, and lower the chance of problems like venous ulcers.
The technologies of venous stents include iliac vein stent technology and wallstent technology. Iliac vein stent technology is a specialized technology intended to address blockages or narrowing in the iliac veins, which are vital blood vessels that transport blood from the legs to the heart. With this technology, stents have expandable mesh tubes that are implanted to restore normal blood flow and alleviate ailments like post-thrombotic syndrome, chronic venous insufficiency, and iliac vein compression syndrome. To ensure long-term patency and few complications, iliac vein stents are designed to be extremely flexible, strong, and resistant to compression. By lowering leg pain, swelling, and the risk of venous ulcers, these stents greatly enhance the quality of life for patients. Additionally, precise placement and integration with surrounding tissues are made easier by advanced designs.
Advancements in Stent Design Technologies is Expected to Boost the Patent Industry Growth
The clinical use of venous stents has increased due to ongoing design advancements that have improved their flexibility, biocompatibility, and durability. The patent applications are also growing because of these advancements, which improve patient outcomes and lower complications, making stenting a more practical and efficient treatment option. For instance, an implantable medical device called the Duo Venous Stent System was introduced by Philips to treat symptomatic venous outflow obstruction in patients suffering from chronic venous insufficiency (CVI). The two stents in the Duo Venous Stent System called the Duo Hybrid and Duo Extend, were designed to meet the difficulties posed by venous anatomy and blockages.
There is an increase in patent activity which focuses on enhancing the performance of venous stents. In 2023, 956 patents were granted which increased to 1,055 by 2024. Patents covering these technologies are crucial for companies and thus impact the venous stent patent landscape.
Increasing Incidence of Venous Diseases is Expected to Propel Venous Stents Patent Industry
The need for venous stents is driven by the rising incidence of diseases like deep vein thrombosis and chronic venous insufficiency, which are frequently made worse by sedentary lifestyles and aging populations. Stenting procedures are required for these conditions to restore blood flow and relieve symptoms such as leg ulcers, pain, and swelling.
The report will cover the following sections in detail:
Analysis by Technology
Analysis by Indication
Analysis by Application
The breakup based on technology includes iliac vein stent technology, wallstent technology, and others. Wallstent technology makes a particular kind of self-expanding stent that is used to treat vascular blockages, especially those that occur in the veins and arteries. These stents, which are composed of a flexible mesh material, provide structural support to maintain the blood vessel open by automatically expanding to the size of the vessel. Conditions like venous blockages, biliary obstructions, and coronary artery disease are frequently treated with wallstent technology.
The United States is one of the leading jurisdictions for venous stent patents, having around 33,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Among the players with venous stents patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the venous stents field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:
It is a global leader in medical technology, headquartered in Dublin, Ireland, and founded in 1949. The company specializes in innovative healthcare solutions across cardiovascular, neurology, diabetes management, and surgical technologies. Medtronic has pioneered advancements like the Hugo™ Robotic-Assisted Surgery System, Micra™ leadless pacemaker, and AI-powered GI Genius™ diagnostic system. It holds numerous patents in deep brain stimulation, robotic surgery, and hybrid closed-loop insulin pumps, emphasizing AI, robotics, and minimally invasive care to improve patient outcomes.
Headquartered in Marlborough, Massachusetts, and founded in 1979, it is a global leader in medical technology. The company specializes in innovative solutions for cardiovascular, neuromodulation, endoscopy, and urology. Key advancements include the SYNERGY™ bioabsorbable stent, WaveWriter Alpha™ SCS for pain management, and EXALT™ disposable duodenoscope to reduce infection risks. With patents in AI, robotics, and minimally invasive devices, Boston Scientific drives innovation to improve patient care worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Edwards Lifesciences Corp, Cook Medical Technologies Llc, and Veniti Inc., among others.
The venous stents patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by:
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
|
Scope of the Report |
Details |
|
Analysis by Technology |
|
|
Analysis by Indication |
|
|
Analysis by Application |
|
|
Key Players Mentioned |
|
|
Geographies Covered |
|
Mini Report
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share